John Giordano

1.5k total citations
38 papers, 747 citations indexed

About

John Giordano is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, John Giordano has authored 38 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 10 papers in Psychiatry and Mental health and 9 papers in Cognitive Neuroscience. Recurrent topics in John Giordano's work include Neurotransmitter Receptor Influence on Behavior (17 papers), Attention Deficit Hyperactivity Disorder (9 papers) and Obsessive-Compulsive Spectrum Disorders (4 papers). John Giordano is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (17 papers), Attention Deficit Hyperactivity Disorder (9 papers) and Obsessive-Compulsive Spectrum Disorders (4 papers). John Giordano collaborates with scholars based in United States, India and Israel. John Giordano's co-authors include Kenneth Blum, Eric R. Braverman, Thomas J.H. Chen, Marlene Oscar‐Berman, Abdalla Bowirrat, Bernard W. Downs, Margaret Madigan, Roger L. Waite, Mark S. Gold and Mallory Kerner and has published in prestigious journals such as PLoS ONE, International Journal of Environmental Research and Public Health and Molecular Neurobiology.

In The Last Decade

John Giordano

36 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Giordano United States	16	323	237	175	165	141	38	747
Sjacko Sobczak Netherlands	12	214 0.7×	296 1.2×	112 0.6×	259 1.6×	160 1.1×	45	851
Kathryn M. Schak United States	20	218 0.7×	296 1.2×	329 1.9×	262 1.6×	206 1.5×	44	1.1k
Andrea Dlugos United States	14	265 0.8×	105 0.4×	221 1.3×	115 0.7×	135 1.0×	17	731
Cathrin Rohleder Germany	19	261 0.8×	184 0.8×	469 2.7×	118 0.7×	159 1.1×	43	1.0k
Isabel Martínez‐Gras Spain	15	175 0.5×	277 1.2×	132 0.8×	94 0.6×	146 1.0×	35	725
Marie‐France Poirier France	17	195 0.6×	412 1.7×	168 1.0×	221 1.3×	200 1.4×	34	964
Bryan K. Tolliver United States	24	571 1.8×	353 1.5×	136 0.8×	201 1.2×	205 1.5×	50	1.2k
Stephanie Collins Reed United States	15	263 0.8×	77 0.3×	286 1.6×	111 0.7×	104 0.7×	24	701
Robin Wilson United Kingdom	13	177 0.5×	222 0.9×	370 2.1×	81 0.5×	194 1.4×	23	691
Jeffrey L. Rausch United States	18	236 0.7×	168 0.7×	202 1.2×	186 1.1×	88 0.6×	29	772

Countries citing papers authored by John Giordano

Since Specialization

Citations

This map shows the geographic impact of John Giordano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Giordano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Giordano more than expected).

Fields of papers citing papers by John Giordano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Giordano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Giordano. The network helps show where John Giordano may publish in the future.

Co-authorship network of co-authors of John Giordano

This figure shows the co-authorship network connecting the top 25 collaborators of John Giordano. A scholar is included among the top collaborators of John Giordano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Giordano. John Giordano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baron, David, Thomas McLaughlin, Mauro Ceccanti, et al.. (2024). Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography. PubMed. 8(1). 1–33. 2 indexed citations

Gupta, Ashim, Abdalla Bowirrat, David Baron, et al.. (2022). Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors. International Journal of Environmental Research and Public Health. 19(1). 552–552. 7 indexed citations

Ceccanti, Mauro, Kenneth Blum, Abdalla Bowirrat, et al.. (2022). Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. Journal of Personalized Medicine. 12(12). 2015–2015. 4 indexed citations

Blum, Kenneth, Debasis Bagchi, Steven A. Kushner, et al.. (2020). Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration. PubMed. 6(3). 9 indexed citations

Giordano, John, et al.. (2019). ON BITCOIN AND SIMMEL’S IDEA OF PERFECT MONEY. 20(1). 52–52. 1 indexed citations

Febo, Marcelo, Kenneth Blum, Rajendra D. Badgaiyan, et al.. (2017). Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z. PLoS ONE. 12(4). e0174774–e0174774. 48 indexed citations

Blum, Kenneth, Stephen J. Schoenthaler, Marlene Oscar‐Berman, et al.. (2014). Drug Abuse Relapse Rates Linked to Level of Education: Can We Repair Hypodopaminergic-Induced Cognitive Decline With Nutrient Therapy?. The Physician and Sportsmedicine. 42(2). 130–145. 10 indexed citations

Blum, Kenneth, David K. Han, Marlene Oscar‐Berman, et al.. (2013). Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs. Health. 5(11). 16–34. 1 indexed citations

McLaughlin, Thomas, Marlene Oscar‐Berman, Thomas Simpatico, et al.. (2013). Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT). Journal of Behavioral Addictions. 2(2). 117–124. 20 indexed citations

10.

Hill, Edward E., David K. Han, Pierre Dumouchel, et al.. (2013). Correction: Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech. PLoS ONE. 8(8). 6 indexed citations

11.

Han, David, Pierre Dumouchel, Najim Dehak, et al.. (2013). Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech. PLoS ONE. 8(7). e69043–e69043. 28 indexed citations

12.

Blum, Kenneth, M. Foster Olive, Kevin Wang, et al.. (2013). Hypothesizing that designer drugs containing cathinones (“bath salts”) have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption. Medical Hypotheses. 81(3). 450–455. 22 indexed citations

13.

Giordano, John, et al.. (2012). Scientific Freedom: an anthology on freedom of scientific research. Bloomsbury eBooks.

14.

Blum, Kenneth, Amanda LC Chen, John Giordano, et al.. (2012). The Addictive Brain: All Roads Lead to Dopamine. Journal of Psychoactive Drugs. 44(2). 134–143. 83 indexed citations

15.

Bowirrat, Abdalla, Thomas J.H. Chen, Marlene Oscar‐Berman, et al.. (2012). Neuropsychopharmacology and Neurogenetic Aspects of Executive Functioning: Should Reward Gene Polymorphisms Constitute a Diagnostic Tool to Identify Individuals at Risk for Impaired Judgment?. Molecular Neurobiology. 45(2). 298–313. 22 indexed citations

16.

Chen, Thomas J.H., Kenneth Blum, Amanda LC Chen, et al.. (2011). Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map. Journal of Psychoactive Drugs. 43(2). 108–127. 35 indexed citations

17.

Bowirrat, Abdalla, Thomas J.H. Chen, Kenneth Blum, et al.. (2010). Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability. Current Neuropharmacology. 8(4). 335–358. 45 indexed citations

18.

Blum, Kenneth, Bernard W. Downs, Eric R. Braverman, et al.. (2010). Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE®device therapy: a case series. Cases Journal. 3(1). 54–54. 5 indexed citations

19.

Blum, Kenneth, Thomas J.H. Chen, Siobhan Morse, et al.. (2010). Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D₂Agonist Therapy: Part 2. Postgraduate Medicine. 122(6). 214–226. 71 indexed citations

20.

Blum, Kenneth, Thomas J.H. Chen, Margaret Madigan, et al.. (2009). Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS). Medical Hypotheses. 74(3). 513–520. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact